期刊
FRONTIERS IN AGING NEUROSCIENCE
卷 14, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2022.1019412
关键词
Alzheimer's disease; small molecule; A beta; tau protein; therapeutic drugs monitoring
资金
- Taishan Scholars Project of Shandong Province
- [tsqn202103108]
This review summarizes small-molecule drugs developed based on the pathogenesis of Alzheimer's disease (AD) and provides a deeper understanding of AD. It aims to assist scientists in finding new and better treatments to gradually conquer the problems associated with AD in the future.
Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative brain disorder with no effective therapeutic drugs currently. The complicated pathophysiology of AD is not well understood, although beta-amyloid (A beta) cascade and hyperphosphorylated tau protein were regarded as the two main causes of AD. Other mechanisms, such as oxidative stress, deficiency of central cholinergic neurotransmitters, mitochondrial dysfunction, and inflammation, were also proposed and studied as targets in AD. This review aims to summarize the small-molecule drugs that were developed based on the pathogenesis and gives a deeper understanding of the AD. We hope that it could help scientists find new and better treatments to gradually conquer the problems related to AD in future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据